Inventor
OLSEN OLE
US52 patents
⚠️ This page may combine multiple inventors who share the name “OLSEN OLE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERACLONE SCIENCES INC
13 patentsUS10087239B2Oct 2, 2018
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC14 citations91
US9464131B2Oct 11, 2016
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC18 citations91
US11319362B2May 3, 2022
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC3 citations83
US10865234B2Dec 15, 2020
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US10836811B2Nov 17, 2020
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
THERACLONE SCIENCES INC1 citations72
US10407493B2Sep 10, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC1 citations72
US12312396B2May 27, 2025
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US12018067B2Jun 25, 2024
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US11584789B2Feb 21, 2023
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations62
US7982012B2Jul 19, 2011
Compositions and methods for the therapy and diagnosis of cytomegalovirus
THERACLONE SCIENCES INC1 citations62
US11845789B2Dec 19, 2023
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies
THERACLONE SCIENCES INC0 citations61
US10239934B2Mar 26, 2019
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
US9920111B2Mar 20, 2018
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity
THERACLONE SCIENCES INC0 citations51
CARLSBERG AS
8 patentsUS5470725ANov 28, 1995
Thermostable (1,3-1,4)-β-glucanase
CARLSBERG AS91 citations89
US7420105B2Sep 2, 2008
Barley for production of flavor-stable beverage
CARLSBERG AS9 citations80
US7838053B2Nov 23, 2010
Barley for production of flavor-stable beverage
CARLSBERG AS6 citations69
US11884972B2Jan 30, 2024
Method to screen for a mutant within a population of organisms by applying a pooling and splitting approach
CARLSBERG AS2 citations65
US12060544B2Aug 13, 2024
Method for producing an extract of cereal and method for processing this extract into beverage
CARLSBERG AS0 citations58
US12428678B2Sep 30, 2025
Method to screen for a mutant within a population of organisms by applying a pooling and splitting approach
CARLSBERG AS0 citations55
US11690341B2Jul 4, 2023
Cereal plants with improved cell wall properties
CARLSBERG AS0 citations53
US12382892B2Aug 12, 2025
Barley with increased hydrolytic enzyme activity
CARLSBERG AS0 citations52
SYSTIMMUNE INC
7 patentsUS11787863B2Oct 17, 2023
Multi-specific antibodies and methods of making and using thereof
SYSTIMMUNE INC6 citations72
US12029761B2Jul 9, 2024
Guidance and Navigation Control proteins and method of making and using thereof
SYSTIMMUNE INC6 citations71
US11518815B2Dec 6, 2022
Anti-ROR1 antibodies and methods of making and using thereof
SYSTIMMUNE INC1 citations71
US12384850B2Aug 12, 2025
Guidance and navigation control proteins and method of making and using thereof
SYSTIMMUNE INC1 citations61
US11987635B2May 21, 2024
Anti-4-1BB antibodies and methods of making and using thereof
SYSTIMMUNE INC0 citations61
US11535667B2Dec 27, 2022
Anti-CD3 antibodies and methods of making and using thereof
SYSTIMMUNE INC0 citations60
US11649286B2May 16, 2023
Tri-specific antibodies
SYSTIMMUNE INC0 citations49
GRANDEA III ANDRES
3 patentsUS8057796B2Nov 15, 2011
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES14 citations90
US8460671B2Jun 11, 2013
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES5 citations82
US8114402B2Feb 14, 2012
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES6 citations82
GRANDEA III ANDRES G
3 patentsUS8916160B2Dec 23, 2014
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G11 citations80
US8974788B2Mar 10, 2015
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G4 citations69
US8858948B2Oct 14, 2014
Compositions and methods for the therapy and diagnosis of influenza
GRANDEA III ANDRES G1 citations48
OLSEN OLE
3 patentsUS8900590B2Dec 2, 2014
Anti-hemagglutinin antibody compositions and methods of use thereof
OLSEN OLE5 citations65
US8852594B2Oct 7, 2014
Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
OLSEN OLE1 citations61
US8268309B2Sep 18, 2012
Compositions and methods for the therapy and diagnosis of cytomegalovirus
OLSEN OLE3 citations61
(unassigned)
2 patentsCARLSBERG BREWERIES AS
2 patentsKNUDSEN SØREN
2 patentsINNOVATIVE DEV & MARKETING
1 patentSENSYACT AB
1 patentCHAN-HUI PO-YING
1 patentARCTIC MEDICAL AS
1 patentINT AIDS VACCINE INITIATIVE INC
1 patentNOVO NORDISK AS
1 patentGADE MORTEN
1 patentShowing the top 50 of 52 patents by PatentIndex Score.